International Stem Cell CORP
ISCO- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001355790
In the last 90 days, International Stem Cell CORP insiders filed 0 open-market purchases and 1 sale; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsLast 90 days, $10.5K in total
- 1
- 13F holdersQ2 2026
- 0
- 13F valueReported value at the end of Q2 2026
- $0
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding ISCO, Q2 2026
No superinvestor reported holding ISCO at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by International Stem Cell CORP insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 15, 2026 (view filing)4:12 PM ET | Sep 11 | 4 days | Maier Paul VDirector | SSale | −32.8K | $0.32 | −$10.5K | −100.0%0 after |
Top 10 13F holders, Q2 2026
The largest institutional positions in International Stem Cell CORP at the end of Q2 2026; share changes are against Q1 2026.
No institution reported holding ISCO in 13F filings for Q2 2026.